Endoscopic submucosal dissection for ultra-low large rectal stromal tumor after preoperative imatinib therapy: A case report and review

J Dig Dis. 2022 Dec;23(12):720-723. doi: 10.1111/1751-2980.13157. Epub 2023 Mar 9.

Authors

Hao Ran Liu¹, Ji Feng², Rui Li¹

Affiliations

¹ Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
² Department of Gastroenterology, The First People's Hospital of Kunshan, Suzhou, Jiangsu Province, China.

PMID: 36756792
DOI: 10.1111/1751-2980.13157

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Endoscopic Mucosal Resection*
Gastrointestinal Stromal Tumors* / drug therapy
Gastrointestinal Stromal Tumors* / surgery
Humans
Imatinib Mesylate / therapeutic use
Neoadjuvant Therapy
Rectal Neoplasms* / drug therapy
Rectal Neoplasms* / pathology
Rectal Neoplasms* / surgery
Rectum / pathology

Substances

Imatinib Mesylate